Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
第一作者:
Xiao-Dong,Zhu
第一单位:
Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
作者:
医学主题词
人类(Humans);癌, 肝细胞(Carcinoma, Hepatocellular);肝切除术(Hepatectomy);肝肿瘤(Liver Neoplasms);预后(Prognosis)
DOI
10.1245/s10434-022-12530-z
PMID
36178565
发布时间
2024-09-16
- 浏览0
Annals of surgical oncology
2782-2790页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



